| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 95,212 | 0.00 | 0 |
| 4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 9,733 | 35.53 k | 95,212 | |
| 18 Nov 24 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | No | 4.17 | 3,908 | 16.30 k | 104,945 |
| 1 Jul 24 | KPRX Kiora Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 1,778 | 7.73 k | 1,778 |
| 29 Sep 23 | KPRX Kiora Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5677 | 0 | 0.00 | 5,000 |
